Zhejiang Youyi Medical Technology Co., Ltd – Trademark Portfolio

Entity Type: 16

Zhejiang Youyi Medical Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include OXYLUME. The owner is based in Jinhua CY, Zhejiang.

4th and 5th floors, No. 640 Jiulong

North Rd.,Dongcheng St.,Yongkang CY

Jinhua CY, Zhejiang 321300 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OXYLUME
OXYLUME
Registered 2025

Trademark Classifications

Zhejiang Youyi Medical Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zhejiang Youyi Medical Technology Co., Ltd have?

Zhejiang Youyi Medical Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Zhejiang Youyi Medical Technology Co., Ltd file in?

Zhejiang Youyi Medical Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhejiang Youyi Medical Technology Co., Ltd's most well-known trademarks?

Zhejiang Youyi Medical Technology Co., Ltd's registered trademark portfolio includes well-known marks such as OXYLUME. These are among 1 currently registered trademark in the portfolio.

What is Zhejiang Youyi Medical Technology Co., Ltd's trademark registration success rate?

Zhejiang Youyi Medical Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.